Prospect Medical Holdings Files Financial Information for Brotman Medical Center

Prospect Medical Holdings, Inc. (NYSE Amex:PZZ) (�Prospect�), which owns and operates five hospitals and manages the medical care of HMO enrollees in Southern California, announced that it has filed a Report on Form 8-K/A with the Securities and Exchange Commission containing the required stand-alone audited and unaudited financial statements, together with pro forma financial information, for Brotman Medical Center (�Brotman�). As previously announced, effective April 14, 2009, Prospect increased its ownership stake in Brotman from approximately 33% to approximately 72%, following Brotman�s financial turnaround and successful emergence from Chapter 11 Proceedings.

Brotman is expected to play an increasingly important role in the Company�s growth plans, with financial performance expected to continue to improve as Prospect�s proven hospital operating model and experienced hospital management team are applied to that operation. Further details may be found in the 8-K/A filing.

Founded in 1924 and based in Culver City, California, Brotman is a 420 licensed-bed acute care hospital that offers a wide range of inpatient and outpatient services, including a 24-hour emergency room, rehabilitation, psychiatric care and chemical dependency services. Following several years of significant operating losses, Brotman voluntarily filed for Chapter 11 Bankruptcy Protection in October 2007. Prospect's hospital management team, along with Brotman�s medical, administrative and other staff worked together to substantially improve the hospital�s operations. After non-recurring restructuring costs, Brotman is now operating profitably for the first time in many years.

ABOUT PROSPECT MEDICAL HOLDINGS

Prospect Medical Holdings operates five hospitals in the greater Los Angeles area and manages the medical care of approximately 183,000 HMO enrollees in Southern California, through a network of approximately 14,000 specialist and primary care physicians.

This press release contains forward-looking statements. Additional written or oral forward-looking statements may be made by Prospect from time to time, in filings with the Securities and Exchange Commission, or otherwise. Statements contained herein that are not historical facts are forward-looking statements. Investors are cautioned that forward-looking statements, including the statements regarding anticipated or expected results, involve risks and uncertainties which may affect the Company's business and prospects, including those outlined in Prospect's Form 10-K filed on December 29, 2008, as well as risks and uncertainties arising from Prospect's acquisition of Alta and ProMed, and the debt incurred by Prospect in connection with those acquisitions. Any forward-looking statements contained in this press release represent our estimates only as of the date hereof, or as of such earlier dates as are indicated, and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change.

Prospect Medical (AMEX:PZZ)
過去株価チャート
から 5 2024 まで 6 2024